Compare CRSP & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRSP | ANF |
|---|---|---|
| Founded | 2013 | 1892 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.8B |
| IPO Year | 2016 | 1996 |
| Metric | CRSP | ANF |
|---|---|---|
| Price | $56.49 | $102.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 11 |
| Target Price | $71.50 | ★ $116.00 |
| AVG Volume (30 Days) | 1.7M | ★ 2.0M |
| Earning Date | 02-10-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.16 |
| EPS | N/A | ★ 10.47 |
| Revenue | $38,337,000.00 | ★ $5,181,407,000.00 |
| Revenue This Year | N/A | $7.63 |
| Revenue Next Year | $718.51 | $4.09 |
| P/E Ratio | ★ N/A | $9.82 |
| Revenue Growth | N/A | ★ 7.57 |
| 52 Week Low | $30.04 | $65.40 |
| 52 Week High | $78.48 | $147.91 |
| Indicator | CRSP | ANF |
|---|---|---|
| Relative Strength Index (RSI) | 51.43 | 38.86 |
| Support Level | $53.37 | $98.80 |
| Resistance Level | $60.73 | $133.11 |
| Average True Range (ATR) | 2.33 | 5.19 |
| MACD | 0.12 | -3.84 |
| Stochastic Oscillator | 47.39 | 13.03 |
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Majority stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.